EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of December 18th, 2020, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Jared Freedberg (“Executive”).
MANUFACTURING AND SUPPLY AGREEMENT between INTERCEPT PHARMA EUROPE LTD. and PHARMAZELL GMBHManufacturing and Supply Agreement • February 25th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), dated the last date of signature (the “Effective Date”), is made by and between Intercept Pharma Europe Ltd., having a location at 2 Pancras Square, Floor 1, London, United Kingdom N1C 4AG (“Intercept”), and, solely for purposes of Section 10.19, Intercept Pharmaceuticals, Inc. (“Intercept Parent”), and PharmaZell GmbH, a corporation organized under the laws of Germany (“PharmaZell”). Intercept and PharmaZell are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENTLicense Agreement • February 25th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”), dated as of March 29, 2011 (the “Effective Date”), is made by and between DAINIPPON SUMITOMO PHARMA CO. LTD., a company organized under the laws of Japan (“DSP”), having a place of business at 6-8 Doshomachi 2-chome, Chuo-ku, Osaka 541-0045 Japan, and INTERCEPT PHARMACEUTICALS, INC., a company organized under the laws of the State of Delaware (“Intercept”), having a place of business at 18 Desbrosses Street, New York, New York 10013. DSP and Intercept are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
